Abstract:Both single nucleotide variants (SNVs) and somatic copy number alterations (SCNAs) accumulate in cancer cells during tumor development, fuelling clonal evolution. However, accurate inference of their coevolution from bulk DNA sequencing is challenging. We present ALPACA (ALlele-specific Phylogenetic Analysis of clone Copy number Alterations), a novel algorithm to allow the practical inference of SNV and SCNA coevolution. ALPACA is framed as an optimisation problem, that takes as input bulk tumor sample copy number mixtures and the tumor phylogenetic tree constructed from SNVs, and deconvolves the optimal, allele-specific integer copy number profiles for every distinct clone present in the tumor. To circumvent the challenge of joint SNV/SCNA inference, we postulate that in high mutation burden tumors all relevant SCNA clones are identifiable by their unique SNVs, hence ALPACA leverages phylogenetic trees constructed from bulk tumor sequencing data using SNVs. Secondly, to restrict the clone-specific copy number search space, ALPACA leverages constraints imposed by multisample sequencing, specifically in cases where clones are present across multiple samples or clones from different samples are phylogenetically related. Finally, ALPACA relies on parsimony and biologically informed constraints to further guide the deconvolution process. We demonstrate that ALPACA infers the copy number evolution of complex simulated tumors with higher accuracy than current state-of-the-art methods. We apply ALPACA to the large, multisample non-small cell lung cancer (NSCLC) cohort from the recent longitudinal, prospective TRACERx421 study, and show that ALPACA uncovers loss of heterozygosity and amplification events in minor subclones that were previously missed using standard approaches. ALPACA's assignment of SCNA driver events to branches of the phylogenetic tree reveals the evolutionary ordering of SNVs and SCNAs during NSCLC tumor evolution, such as late focal amplifications affecting the TERT gene locus occurring in subclones which expand and dominate a tumor sample. ALPACA enables an in-depth analysis of the coevolution of mutations and SCNAs in the tumor's evolutionary history, revealing distinct patterns of copy number evolution. Notably, ALPACA identifies common patterns of copy number changes across the genome characterizing metastatic seeding clones, revealing that they harbor an increased number of SCNAs compared to clones that do not metastasize. Additionally, ALPACA uncovers subclonal enrichment for CCND1 amplification in primary tumor subclones that seed metastasis, and an overall increase of SCNA events occurring in both tumors with polyclonal seeding and extrathoracic metastases. Clone-level results obtained with ALPACA can offer new clinical insights and enable new types of analysis, e.g. copy number signature analysis including temporal order of SCNA acquisition. Citation Format: Piotr Pawlik, Kristiana K. Grigoriadis, Abigail Bunkum, Simone Zaccaria, Nicholas McGranahan, Charles Swanton. A novel algorithm for deconvolving cancer allele-specific clone copy number and copy number evolution [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 1200.

Refphase: Multi-sample phasing reveals haplotype-specific copy number heterogeneity

Pharming: Joint Clonal Tree Reconstruction of SNV and CNA Evolution from Single-cell DNA Sequencing of Tumors

Single-cell copy number calling and event history reconstruction

DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly

High resolution copy number inference in cancer using short-molecule nanopore sequencing

SCONCE: a method for profiling copy number alterations in cancer evolution using single-cell whole genome sequencing

Inferring clonal evolution of tumors from single nucleotide somatic mutations

Clonecna: Detecting Subclonal Somatic Copy Number Alterations in Heterogeneous Tumor Samples from Whole-Exome Sequencing Data

A statistical learning method for simultaneous copy number estimation and subclone clustering with single-cell sequencing data

PhyClone: Accurate Bayesian reconstruction of cancer phylogenies from bulk sequencing

Abstract 6218: Haplotype-resolved analysis of cancer genomes and epigenomes using Oxford Nanopore sequencing

HaplotypeCN: Copy Number Haplotype Inference with Hidden Markov Model and Localized Haplotype Clustering

Inferring allele-specific copy number aberrations and tumor phylogeography from spatially resolved transcriptomics

scGAL: unmask tumor clonal substructure by jointly analyzing independent single-cell copy number and scRNA-seq data

Abstract 2704: Resolving clone-and haplotype-specific copy number variation and DNA methylation in heterogeneous tumors with nanopore sequencing

Abstract 1200: A novel algorithm for deconvolving cancer allele-specific clone copy number and copy number evolution

HATCHet2: clone- and haplotype-specific copy number inference from bulk tumor sequencing data

Reconstructing tumor clonal heterogeneity and evolutionary relationships based on tumor DNA sequencing data

CLImAT-HET: Detecting Subclonal Copy Number Alterations and Loss of Heterozygosity in Heterogeneous Tumor Samples from Whole-Genome Sequencing Data.

Robust analysis of allele-specific copy number alterations from scRNA-seq data with XClone

High-resolution detection of copy number alterations in single cells with HiScanner